US Headquarters
PO Box 110145
Research Triangle Park
NC 27709-5145
United States
Phone: +1 919-226-3200
Fax: +1 919-474-2269
Toll Free: 888-728-4366 (888-PATHEON)
Website: www.patheon.com
Email:
doingbusiness@patheon.com
New:
Press Release
About Patheon Inc.
Patheon Inc. (TSX:PTI;
www.patheon.com) is a leading global provider of contract
development and manufacturing services to the global
pharmaceutical industry. Patheon prides itself in
providing the highest quality products and services to
more than 300 of the world’s leading pharmaceutical and
biotechnology companies. Patheon’s services range
from preclinical development through commercial
manufacturing of a full array of dosage forms including
parenteral, solid, semi-solid and liquid forms.
Patheon uses many innovative technologies including
single-use disposables, Liquid-Filled Hard Capsules and a
variety of modified release technologies.
Products and Services
Patheon’s comprehensive
range of fully integrated Pharmaceutical Development
Services includes pre-formulation, formulation, analytical
development, clinical manufacturing, scale-up and
commercialization. Patheon can take customers direct
to clinic with global clinical packaging and distribution
services and Patheon’s Quick to Clinic™ programs can
accelerate early phase development project to clinical
trials while minimizing the consumption of valuable API.
Markets served
Patheon’s integrated
development and manufacturing network of 11 facilities,
and 6 development centers across North America and Europe,
strives to ensure that customer products can be launched
with confidence anywhere in the world.
Financial
Patheon Inc. is a Canadian
public company, which trades under the symbol PTI on the
Toronto Stock Exchange. Revenues (before
repositioning costs) for the year ended October 31, 2006
were USD $712 versus revenues of USD $698 in 2005.
Press Release
